# Accupower ® HCV Performance Evaluation Quant Kit Bioneer Existation™FA 96/384

> **NCT06623058** · — · NOT_YET_RECRUITING · sponsor: **CerbaXpert** · enrollment: 45 (estimated)

## Conditions studied

- HEPATITIS C (HCV)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06623058
- **Lead sponsor:** CerbaXpert
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-05-30
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2024-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06623058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06623058, "Accupower ® HCV Performance Evaluation Quant Kit Bioneer Existation™FA 96/384". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06623058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*